On or around 12/20/2011 (Stipulation and order of dismissal (voluntary dismissal))
Filing Date: July 31, 2009
According to a press release dated July 31, 2009, the complaint alleges that defendants violated Section 14(e) of the 1934 Act, inter alia, by issuing a false and misleading Offer to Purchase and Schedule 14D-9 which fail to apprise Medarex shareholders of the true bases of Medarex's financial valuation. The complaint also alleges that defendants breached their fiduciary duties, or aided and abetted the breach of fiduciary duties, by recommending an unfairly low tender offer to Medarex shareholders. The complaint names as defendants the directors of Medarex, Bristol-Myers, and Puma Acquisition Company, Bristol-Myers' wholly-owned subsidiary. The complaint seeks injunctive and monetary relief.
On March 7, 2011, the Federal Action was stayed until the termination of all appellate proceedings in the State Court Action.
According to the Stipulation and Order of Dismissal with Prejudice signed by Judge Freda L. Wolfson on December 19, 2011, three related federal class actions were dismissed with prejudice in relation to a settlement of a similar action in state court.
Company & Securities Information
Defendant: Medarex, Inc.
Industry: Biotechnology & Drugs
Headquarters: United States
Ticker Symbol: MEDX
Company Market: NASDAQ
Market Status: Public (Listed)
About the Company & Securities Data
"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.
In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
Class Action Complaint For Violation Of Securities Laws
Stipulation And Order Staying Actions
U.S. District Court Civil Docket
—Reference Complaint Complaint Related Data is not available
Related District Court Filings
Shareholder Class Action Complaint
Amended Shareholder Class Action Complaint
U.S. District Court Civil Docket
Related State Court Filings
Amended Class Action Complaint for Breaches of Fiduciary Duty
Objections To Proposed Stipulation Of Settlement
Objection to Class Action Settlement
Certification of Steven Innaimo
Submission Of Defendants In Response To Objections To The Settlement
Certification of Michael Battista
Certification Of Peter S. Pearlman In Support Of Final Approval Of Settlement And An Award Of Attorneys' Fees And Reimbursement Of Expenses
Compendium Of Unreported Cases Cited In Plaintiffs' Memorandum Of Law In Support Of Final Approval Of Settlement And An Award Of Attorneys' Fees And Reimbursement Of Expenses
Certificate of Service
Memorandum Of Law In Support Of Plaintiffs' Motion For Final Approval Of Class Action Settlement, Award Of Attorneys' Fees, And Reimbursment Of Expenses
Response To Plaintiff's Counsel Objections To Plaintiff's Objections
Request Immediate Postponement of July 12, 2009 Court Hearing Date Since Defendants Did Not Notify the Correct Record Holders.
Motion for Reconsideration Out Of Time As New Evident Has Surfaced Showing Violations of Federal Security Laws, Un-Ethical Actions of Plaintiff Attorneys, Misleading Statements by Defendant and Plaintiff Attorneys during July 12, 2009 Hearing,